AU7993600A - Non-invasive tumor imaging by tumor-targeted bacteria - Google Patents

Non-invasive tumor imaging by tumor-targeted bacteria

Info

Publication number: AU7993600A
Authority: AU; Australia
Prior art keywords: tumor; targeted bacteria; invasive; imaging; tumor imaging
Prior art date: 1999-10-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU79936/00A

Inventor

David G. Bermudes

Ronald G Blasberg

Ivan Cheung-Lam King

Juri G. Tjuvajev

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Vion Pharmaceuticals Inc

Memorial Sloan Kettering Cancer Center

Original Assignee

Vion Pharmaceuticals Inc

Memorial Sloan Kettering Cancer Center

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-04

Filing date

2000-10-04

Publication date

2001-05-10

2000-10-04 Application filed by Vion Pharmaceuticals Inc, Memorial Sloan Kettering Cancer Center filed Critical Vion Pharmaceuticals Inc

2001-05-10 Publication of AU7993600A publication Critical patent/AU7993600A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0045—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0045—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
- A61K49/0047—Green fluorescent protein [GFP]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0097—Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Radiology & Medical Imaging (AREA)
Pathology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU79936/00A 1999-10-04 2000-10-04 Non-invasive tumor imaging by tumor-targeted bacteria Abandoned AU7993600A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US15762099P	1999-10-04	1999-10-04
US60157620		1999-10-04
PCT/US2000/027397 WO2001025399A2 (en)	1999-10-04	2000-10-04	Non-invasive tumor imaging by tumor-targeted bacteria

Publications (1)

Publication Number	Publication Date
AU7993600A true AU7993600A (en)	2001-05-10

Family

ID=22564528

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU79936/00A Abandoned AU7993600A (en)	1999-10-04	2000-10-04	Non-invasive tumor imaging by tumor-targeted bacteria

Country Status (4)

Country	Link
EP (1)	EP1414499A4 (en)
AU (1)	AU7993600A (en)
CA (1)	CA2386806A1 (en)
WO (1)	WO2001025399A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2452876A1 (en) *	2001-07-09	2003-01-23	Anticancer, Inc.	Imaging infection using fluorescent protein as a marker
EP1281767A3 (en) *	2001-07-31	2003-05-28	Aladar A. Szalay	Light emitting microorganisms and cells for diagnosis and therapy of tumors
EP1281772A1 (en) *	2001-07-31	2003-02-05	Aladar A. Szalay	Light-emitting microorganisms and cells for tumour diagnosis/therapy
EP1914316B1 (en) *	2001-08-01	2009-12-16	Genelux Corporation	LIVP strain of vaccinia virus for diagnosis and therapy of tumours
CN1304559C (en) *	2001-10-09	2007-03-14	杭州康科生物技术有限公司	Oncolytic microorganism expressing heat shock protein and its application
JP4350519B2 (en) *	2001-12-31	2009-10-21	アンチキャンサーインコーポレーテッド	System for monitoring tumor treatment with bacteria
EP1369491A1 (en) *	2002-06-05	2003-12-10	Aladar A. Szalay	Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
JP4634710B2 (en) *	2002-07-31	2011-02-16	ゲネルクスコーポレーション	Microorganisms and cells for tumor diagnosis and treatment
WO2004062597A2 (en) *	2003-01-09	2004-07-29	The Trustees Of The University Of Pennsylvania	Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
SG179291A1 (en)	2003-06-18	2012-04-27	Genelux Corp	Modified recombinant vaccinia viruses and other microorganisms, uses thereof
AU2005260697B2 (en) *	2004-06-29	2011-10-06	Anticancer, Inc.	Cancer selective auxotrophs
US8642009B2 (en)	2005-12-16	2014-02-04	Catherine M. Shachaf	Diagnostic system for the detection of skin cancer
WO2009126189A1 (en) *	2008-01-11	2009-10-15	Genelux Corporation	Methods and compositions for detection of bacteria and treatment of diseases and disorders
WO2012112317A1 (en) *	2011-02-15	2012-08-23	Albert Einstein College Of Medicine Of Yeshiva University	Radiobacteria for therapy of cancer
EP2895205B1 (en) *	2012-09-14	2022-01-05	The Johns Hopkins University	18f-fluorodeoxysorbitol for use in identifying an infectious prokaryotic enterobacteriaceae organism in a mammalian host
US10676723B2 (en)	2015-05-11	2020-06-09	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en)	2016-12-07	2021-11-23	David Gordon Bermudes	Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
JP7097438B2 (en)	2017-07-11	2022-07-07	アクティム・セラピューティクス・インコーポレイテッド	Genetically engineered immunostimulatory bacterial strains and their use
SG11202100023XA (en)	2018-07-11	2021-01-28	Actym Therapeutics Inc	Engineered immunostimulatory bacterial strains and uses thereof
EP3844276A2 (en)	2018-08-28	2021-07-07	Actym Therapeutics, Inc.	Engineered immunostimulatory bacterial strains and uses thereof
KR102110993B1 (en) *	2018-12-20	2020-05-14	한국생명공학연구원	Composition for diagnosing, preventing or treating cancer comprising Klebsiella aerogenes as active ingredient
US12024709B2 (en)	2019-02-27	2024-07-02	Actym Therapeutics, Inc.	Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment
CA3176660A1 (en)	2019-02-27	2020-09-03	Actym Therapeutics, Inc.	Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment
CA3161450A1 (en)	2019-11-12	2021-05-20	Actym Therapeutics, Inc.	Immunostimulatory bacteria delivery platforms and their use for delivery of therapeutic products
EP4196139A2 (en)	2020-08-12	2023-06-21	Actym Therapeutics, Inc.	Immunostimulatory bacteria-based vaccines, therapeutics, and rna delivery platforms
JP2024542173A (en)	2021-11-09	2024-11-13	アクティム・セラピューティクス・インコーポレイテッド	Immunostimulatory bacteria for converting macrophages to a phenotype suitable for treatment and companion diagnostics for identifying subjects for treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8318575D0 (en) *	1983-07-08	1983-08-10	Cobbold S P	Antibody preparations
US4839293A (en) *	1986-02-24	1989-06-13	The Trustees Of Columbia University In The City Of New York	DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
US4863713A (en) *	1986-06-23	1989-09-05	The Board Of Trustees Of Leland Stanford Jr. Univ.	Method and system for administering therapeutic and diagnostic agents
US5631236A (en) *	1993-08-26	1997-05-20	Baylor College Of Medicine	Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
US5703056A (en) *	1995-03-15	1997-12-30	Sloan-Kettering Institute For Cancer Research	Non-invasive imaging of gene transfer
US5681745A (en) *	1995-05-01	1997-10-28	Trustees Of Boston University	Biotin-binding containment systems
US6190657B1 (en) *	1995-06-07	2001-02-20	Yale University	Vectors for the diagnosis and treatment of solid tumors including melanoma
US5824538A (en) *	1995-09-06	1998-10-20	The United States Of America As Represented By The Secretary Of The Army	Shigella vector for delivering DNA to a mammalian cell
US5997881A (en) *	1995-11-22	1999-12-07	University Of Maryland, Baltimore	Method of making non-pyrogenic lipopolysaccharide or A
JP2002500001A (en) *	1997-09-10	2002-01-08	ヴァイオンファーマシューティカルズ、インコーポレーテッド	Genetically modified tumor-targeting bacteria with reduced toxicity

2000
- 2000-10-04 AU AU79936/00A patent/AU7993600A/en not_active Abandoned
- 2000-10-04 WO PCT/US2000/027397 patent/WO2001025399A2/en not_active Application Discontinuation
- 2000-10-04 CA CA002386806A patent/CA2386806A1/en not_active Abandoned
- 2000-10-04 EP EP00970577A patent/EP1414499A4/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP1414499A2 (en)	2004-05-06
WO2001025399A3 (en)	2001-08-23
CA2386806A1 (en)	2001-04-12
WO2001025399A2 (en)	2001-04-12
EP1414499A4 (en)	2004-05-06

Publication	Publication Date	Title
AU7993600A (en)	2001-05-10	Non-invasive tumor imaging by tumor-targeted bacteria
AU2002362608A1 (en)	2003-04-07	Cardiac catheter imaging system
AU7502000A (en)	2001-04-24	Ultrasound imaging system
AU2492000A (en)	2000-07-24	Implantable neuro-stimulator
AU7656800A (en)	2001-04-17	Milking arrangement
EP1061332A3 (en)	2003-01-29	Shearographic imaging machine
AU5480299A (en)	2000-11-17	Refrigeration-shelf-stable pasteurized or ultra-pasteurized infant formula
AU4947300A (en)	2001-01-30	Catheter with distal-end engaging means
AU7310400A (en)	2001-04-30	3-dimensional ultrasonic imaging
AU5547000A (en)	2001-01-02	Novel treatment
AU2068299A (en)	1999-08-02	Ultrasound contrast imaging
AU7882900A (en)	2001-03-19	Hydrotherapy bed
AU6599800A (en)	2001-03-05	Endoscope
AU7817500A (en)	2001-04-17	Method of tumor imaging
GB2353477B (en)	2003-04-30	Medical endoscope
AU3978700A (en)	2000-11-14	Medical use
AU7924400A (en)	2001-07-09	Bed linen
AU4556800A (en)	2000-11-10	Novel treatment
AU7730100A (en)	2001-04-30	Endoscope system
AU1163101A (en)	2001-05-30	Diagnostic methods
GB0001443D0 (en)	2000-03-08	Medical endoscope
AU5124500A (en)	2000-11-17	Tumor necrosis factor-gamma
AU4416500A (en)	2000-11-14	Tomographic system
AU1043601A (en)	2001-05-08	Medical use
AU4456800A (en)	2000-11-02	Human hac3

Legal Events

Date	Code	Title	Description
2002-06-06	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase